Erik Kohlbrenner

3.2k total citations · 1 hit paper
44 papers, 2.4k citations indexed

About

Erik Kohlbrenner is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Erik Kohlbrenner has authored 44 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 25 papers in Molecular Biology and 21 papers in Genetics. Recurrent topics in Erik Kohlbrenner's work include Virus-based gene therapy research (20 papers), Viral Infections and Immunology Research (16 papers) and Viral Infectious Diseases and Gene Expression in Insects (9 papers). Erik Kohlbrenner is often cited by papers focused on Virus-based gene therapy research (20 papers), Viral Infections and Immunology Research (16 papers) and Viral Infectious Diseases and Gene Expression in Insects (9 papers). Erik Kohlbrenner collaborates with scholars based in United States, United Kingdom and France. Erik Kohlbrenner's co-authors include Roger J. Hajjar, Kiyotake Ishikawa, Sergei Zolotukhin, Thomas Weber, Kenneth Fish, Ludovic Bénard, Nicholas Muzyczka, Shihong Zhang, Jiqiu Chen and George Aslanidi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

Erik Kohlbrenner

44 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FTO-Dependent N ⁶ -Methyladenosine Regulates Cardiac Function During Remodeling and Repair

2018 452 citations Prabhu Mathiyalagan, Yassine Sassi et al. Circulation profile →

Peers

Countries citing papers authored by Erik Kohlbrenner

Since Specialization

Citations

This map shows the geographic impact of Erik Kohlbrenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Kohlbrenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Kohlbrenner more than expected).

Fields of papers citing papers by Erik Kohlbrenner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Kohlbrenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Kohlbrenner. The network helps show where Erik Kohlbrenner may publish in the future.

Co-authorship network of co-authors of Erik Kohlbrenner

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Kohlbrenner. A scholar is included among the top collaborators of Erik Kohlbrenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Kohlbrenner. Erik Kohlbrenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AAV delivery strategy with mechanical support for safe and efficacious cardiac gene transfer in swine 2024 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), Olympia Bikou, (unknown), Taro Kariya, Kelly P. Yamada, Erik Kohlbrenner, Lifan Liang, (unknown), Shin Watanabe, Roger J. Hajjar, Kiyotake Ishikawa	9
2	Endobronchial Aerosolized AAV1.SERCA2a Gene Therapy in a Pulmonary Hypertension Pig Model: Addressing the Lung Delivery Bottleneck 2022 ·Human Gene Therapy ·Olympia Bikou, (unknown), Kelly P. Yamada, Taro Kariya, Jaume Agüero, Alexandra June Gordon, (unknown), Tadao Aikawa, Erik Kohlbrenner, Kenneth Fish, Roger J. Hajjar, Kiyotake Ishikawa	6
3	AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis 2019 ·Molecular Therapy ·Malik Bisserier, Javier Milara, (unknown), Sarah M Gubara, (unknown), Carlos Bueno‐Betí, Elena Chepurko, Erik Kohlbrenner, Michael G. Katz, Sima T. Tarzami, Julio Cortijo, Jane A. Leopold, Roger J. Hajjar, Yassine Sassi, Lahouaria Hadri	33
4	Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension 2018 ·Journal of Molecular and Cellular Cardiology ·Benjamin Strauss, Yassine Sassi, Carlos Bueno‐Betí, Zeki Ilkan, Nour Raad, Marine Cacheux, Malik Bisserier, Irene C. Turnbull, Erik Kohlbrenner, Roger J. Hajjar, Lahouaria Hadri, Fadi G. Akar	24
5	Abstract 15439: AAV-Containing Exosomes as a Novel Vector to Improve AAV-Mediated Myocardial Gene Delivery in Resistance to Neutralizing Antibody 2017 ·Circulation ·Yaxuan Liang, Prabhu Mathiyalagan, Erik Kohlbrenner, Elena Chepurko, Dongtak Jeong, Delaine K. Ceholski, Nicole Dubois, Roger J. Hajjar, Susmita Sahoo	5
6	Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice 2017 ·Nature Communications ·(unknown), (unknown), (unknown), Vikas N. O’Reilly-Shah, (unknown), Erik Kohlbrenner, Joseph J. McArdle, Louis J. Dell’Italia, Jerry R. Mendell, Lai‐Hua Xie, Roger J. Hajjar, Dongsheng Duan, Diego Fraidenraich, Gopal J. Babu	80
7	Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart Failure 2017 ·Journal of the American College of Cardiology ·Shin Watanabe, Kiyotake Ishikawa, Kenneth Fish, Jae Gyun Oh, Lukas J. Motloch, Erik Kohlbrenner, Philyoung Lee, Chaoqin Xie, Ahyoung Lee, Lifan Liang, Changwon Kho, (unknown), (unknown), Scott Wilson, R. Jude Samulski, Evangelia G. Kranias, Thomas Weber, Fadi G. Akar, Roger J. Hajjar	33
8	Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension 2016 ·Journal of the American College of Cardiology ·Jaume Agüero, Kiyotake Ishikawa, Lahouaria Hadri, Carlos G. Santos‐Gallego, Kenneth Fish, Erik Kohlbrenner, Nadjib Hammoudi, Changwon Kho, Ah Young Lee, Borja Ibáñez, Ana García‐Álvarez, Krisztina M. Zsebo, Bradley A. Maron, Maria Plataki, Valentı́n Fuster, Jane A. Leopold, Roger J. Hajjar	53
9	Production and Characterization of Vectors Based on the Cardiotropic AAV Serotype 9 2016 ·Methods in molecular biology ·Erik Kohlbrenner, Thomas Weber	15
10	Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure 2014 ·Gene Therapy ·Antoine H. Chaanine, Mathieu Nonnenmacher, Erik Kohlbrenner, Dayong Jin, Jason C. Kovacic, Fadi G. Akar, Roger J. Hajjar, Thomas Weber	20
11	Cardiac Surgical Delivery of the Sarcoplasmic Reticulum Calcium ATPase Rescues Myocytes in Ischemic Heart Failure 2013 ·The Annals of Thoracic Surgery ·Anthony S. Fargnoli, Michael G. Katz, (unknown), (unknown), (unknown), Nury Steuerwald, Sriparna Ghosh, (unknown), (unknown), Richard D. Williams, Erik Kohlbrenner, Hansell H. Stedman, Roger J. Hajjar, Charles R. Bridges	20
12	Plasticity of Surface Structures and β ₂ -Adrenergic Receptor Localization in Failing Ventricular Cardiomyocytes During Recovery From Heart Failure 2012 ·Circulation Heart Failure ·Alexander R. Lyon, Viacheslav O. Nikolaev, Michele Miragoli, Markus B. Sikkel, (unknown), Ludovic Bénard, Jean‐Sébastien Hulot, Erik Kohlbrenner, Roger J. Hajjar, Nicholas S. Peters, Yuri E. Korchev, Ken MacLeod, Siân E. Harding, Julia Gorelik	81
13	CXCR4 gene transfer prevents pressure overload induced heart failure 2012 ·Journal of Molecular and Cellular Cardiology ·Thomas J. LaRocca, Dongtak Jeong, Erik Kohlbrenner, Ah Young Lee, (unknown), Roger J. Hajjar, Sima T. Tarzami	29
14	Quantification of AAV Particle Titers by Infrared Fluorescence Scanning of Coomassie-Stained Sodium Dodecyl Sulfate–Polyacrylamide Gels 2012 ·Human Gene Therapy Methods ·Erik Kohlbrenner, Els Henckaerts, Kleopatra Rapti, Ronald E. Gordon, R. Michael Linden, Roger J. Hajjar, Thomas Weber	26
15	SERCA2a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure 2011 ·Circulation Arrhythmia and Electrophysiology ·Alexander R. Lyon, Mark L. Bannister, (unknown), Emma Pearce, Amir Sepehripour, Sukhpreet Singh Dubb, Edwin García, Peter O’Gara, Lifan Liang, Erik Kohlbrenner, Roger J. Hajjar, Nicholas S. Peters, Philip A. Poole‐Wilson, Ken MacLeod, Siân E. Harding	138
16	Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats 2011 ·Journal of Molecular and Cellular Cardiology ·Elie R. Chemaly, Lahouaria Hadri, Shihong Zhang, Maengjo Kim, Erik Kohlbrenner, (unknown), Lifan Liang, Jiqiu Chen, K‐Raman Purushothaman, Roger J. Hajjar, Djamel Lebeche	69
17	Neutralizing Antibodies Against AAV Serotypes 1, 2, 6, and 9 in Sera of Commonly Used Animal Models 2011 ·Molecular Therapy ·Kleopatra Rapti, (unknown), Erik Kohlbrenner, Kiyotake Ishikawa, Dennis Ladage, Sergei Zolotukhin, Roger J. Hajjar, Thomas Weber	131
18	Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 7 2007 ·Acta Crystallographica Section F Structural Biology and Crystallization Communications ·Odayme Quesada, Brittney L. Gurda, L. Govindasamy, Robert McKenna, Erik Kohlbrenner, George Aslanidi, Sergei Zolotukhin, Nicholas Muzyczka, Mavis Agbandje‐McKenna	18
19	Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5 2005 ·Acta Crystallographica Section F Structural Biology and Crystallization Communications ·Michael A. DiMattia, L. Govindasamy, Hazel C. Levy, Brittney L. Gurda, (unknown), Erik Kohlbrenner, John A. Chiorini, Robert McKenna, Nicholas Muzyczka, Sergei Zolotukhin, Mavis Agbandje‐McKenna	37
20	Successful Production of Pseudotyped rAAV Vectors Using a Modified Baculovirus Expression System 2005 ·Molecular Therapy ·Erik Kohlbrenner, George Aslanidi, Kevin Nash, Stanislav Shklyaev, Martha Campbell‐Thompson, Barry J. Byrne, Richard O. Snyder, Nicholas Muzyczka, Kenneth H. Warrington, Sergei Zolotukhin	106

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact